Pharmaceutical News

RSS

Study shows slight increase in Guillain-Barre syndrome risk with adenovirus COVID vaccines

Study investigates the link between COVID-19 vaccines and autoimmune/neurological diseases, focusing on Guillain-Barre syndrome (GBS) risks associated with adenovirus vector vaccines.

16 Jan 2024

Study warns of increased risks in heart patients using ED drugs with nitrates

A Swedish study reveals higher risks for men with cardiovascular disease using erectile dysfunction drugs (PDE5 inhibitors) alongside nitrate medication, potentially increasing morbidity and mortality.

15 Jan 2024

mRNA COVID-19 vaccines highly effective in preventing hospitalizations among adolescents in Nordic study

Study evaluated the effectiveness of mRNA COVID-19 vaccines (BNT162b2, mRNA-1273, and heterologous schedules) in preventing hospitalization among adolescents in Nordic countries, finding high protection rates of 73% to 86% at six months.

14 Jan 2024

Paxlovid treatment in 20% of COVID-19 patients could avert 850,000 hospitalizations, save up to $170 billion

A study in the Emerging Infectious Diseases journal shows treating 20% of COVID-19 patients with Paxlovid could save up to 0.85 million lives and reduce the economic burden by US $170.17 billion in the US.

14 Jan 2024

Bivalent COVID-19 vaccines show higher effectiveness against thromboembolic events

Study finds bivalent mRNA COVID-19 vaccines are more effective than monovalent vaccines in preventing thromboembolic events in older adults and those with end-stage renal disease.

14 Jan 2024

Planning prompts show promise in improving prescribing safety

Physicians who are notified that a patient has died of a drug overdose are more judicious in issuing controlled substances if the notification includes a plan for what to do during subsequent patient visits, according to a study published today in Nature Communications.

13 Jan 2024

FDA-approved drug may help to decrease pain after surgery, study finds

Researchers in the Department of Anesthesia and Perioperative Medicine at the Medical University of South Carolina (MUSC) have found that an FDA-approved drug may help to decrease pain after surgery.

12 Jan 2024

Trump official who OK’d drugs from Canada chairs company behind Florida’s import plan

The Food and Drug Administration's unprecedented approval of Florida's plan to import drugs from Canada was made possible only after Alex Azar, as the Trump administration's Health and Human Services secretary, certified that bringing medicines over the border could be done safely.

12 Jan 2024

FluidForm Bio successfully demonstrates advancements in engineered heart tissues with FRESH™ 3D bioprinting

FluidForm Bio, a leader in developing life-like human tissue to treat disease, shares recent advancements in building human cardiac tissues using FRESH™ 3D bioprinting.

From FluidForm Bio™ 11 Jan 2024

Study shows engineered antibodies significantly boost Omicron neutralization

Researchers engineered IgA antibodies from IgG monoclonals, enhancing neutralization against Omicron by up to 75-fold and offering protection in mice models.

10 Jan 2024

UQ researchers launch the world's biggest drug survey

Researchers from The University of Queensland have launched the world's biggest drug survey, to gain insight into drug use around the globe.

9 Jan 2024

Nirmatrelvir treatment shows no link to reduced long-COVID risk, study reveals

Recent study reveals nirmatrelvir treatment during acute COVID-19 does not lower the risk of post-acute COVID-19 symptoms, nor is it associated with symptomatic rebound.

8 Jan 2024

Diabetes drugs may help curb alcohol dependence

In social media posts on the community network Reddit, users reported reduced cravings for alcohol when taking drugs intended to treat Type 2 diabetes and obesity.

8 Jan 2024

Genetic keys to COVID-19 vaccine response unlocked

A genome-wide association study in the U.K. Biobank reveals genetic factors influencing IgG serostatus against SARS-CoV-2, highlighting the role of HLA class II genes in variable immune responses to COVID-19 vaccines.

7 Jan 2024

Combining ezetimibe and bempedoic acid effectively lowers cholesterol in statin-intolerant patients

A simulation study analyzing over two million German outpatients found that combining ezetimibe and bempedoic acid effectively reduces LDL cholesterol in statin-intolerant patients with hypercholesterolemia.

7 Jan 2024

Paxlovid does not reduce long COVID risk in vaccinated individuals, study finds

A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.

4 Jan 2024

Combination therapy of dapagliflozin and semaglutide shows superior efficacy in type 2 diabetes management

Study demonstrates that combining dapagliflozin and semaglutide significantly improves glycemic control and other health parameters in type 2 diabetes patients, outperforming dapagliflozin alone.

3 Jan 2024

EZH2 inhibitors show promise in regenerating insulin-producing cells for type 1 diabetes treatment

Study explores the potential of EZH2 inhibitors GSK126 and Tazemetostat in stimulating β-cell regeneration from pancreatic ductal progenitor cells, offering a novel therapeutic approach for Type 1 Diabetes.

3 Jan 2024

New study demystifies clinicians' decision-making process for drug-drug interactions

Drug-drug interactions causing adverse effects are common and can cause significant patient harm and even death.

3 Jan 2024

Mount Sinai study provides a mechanistic explanation for variations in individual responses to drugs

Mount Sinai researchers have shown for the first time that a person's beliefs related to drugs can influence their own brain activity and behavioral responses in a way comparable to the dose-dependent effects of pharmacology.

3 Jan 2024

Previous
1
...
27
28
29
30
31
32
33
...
1433
Next

Pharmaceutical News

Study shows slight increase in Guillain-Barre syndrome risk with adenovirus COVID vaccines

Study warns of increased risks in heart patients using ED drugs with nitrates

mRNA COVID-19 vaccines highly effective in preventing hospitalizations among adolescents in Nordic study

Paxlovid treatment in 20% of COVID-19 patients could avert 850,000 hospitalizations, save up to $170 billion

Bivalent COVID-19 vaccines show higher effectiveness against thromboembolic events

Planning prompts show promise in improving prescribing safety

FDA-approved drug may help to decrease pain after surgery, study finds

Trump official who OK’d drugs from Canada chairs company behind Florida’s import plan

FluidForm Bio successfully demonstrates advancements in engineered heart tissues with FRESH™ 3D bioprinting

Study shows engineered antibodies significantly boost Omicron neutralization

UQ researchers launch the world's biggest drug survey

Nirmatrelvir treatment shows no link to reduced long-COVID risk, study reveals

Diabetes drugs may help curb alcohol dependence

Genetic keys to COVID-19 vaccine response unlocked

Combining ezetimibe and bempedoic acid effectively lowers cholesterol in statin-intolerant patients

Paxlovid does not reduce long COVID risk in vaccinated individuals, study finds

Combination therapy of dapagliflozin and semaglutide shows superior efficacy in type 2 diabetes management

EZH2 inhibitors show promise in regenerating insulin-producing cells for type 1 diabetes treatment

New study demystifies clinicians' decision-making process for drug-drug interactions

Mount Sinai study provides a mechanistic explanation for variations in individual responses to drugs

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News